Genesis AI ranks 72 on the Humanoids 100 with a score of 58; Dexmate ranks 73 with 57. Dexmate is ahead on production and leverage. Genesis AI is ahead on commercials, progress and firepower. Level on deployment, technology and positioning. Dexmate is based in United States, Genesis AI in Palo Alto, United States. Genesis AI: Private, founded 2024. Dexmate is named in 12 signals and Genesis AI in 64.
Dexmate develops and commercially offers Vega, a general-purpose wheeled humanoid robot with mobile manipulation, extended reach, lifting capability and multimodal AI.
Darker bar: ahead of the other company on that measure.
Dexmate is a US robotics company (Santa Clara, founded 2024) whose VEGA combines high-payload arms, a foldable torso, and an omnidirectional base with an integrated Physical AI development platform (the robot as one part of a tooling product). It has a corporate-Asia validation chain: an LG Technology Ventures investment plus an LG CNS commercialization partnership (March 2026) and an NEC Orchestrating Future Fund investment (August 2025), two Asian IT giants as channels within six months. It is pre-revenue class ($33-41M raised).
12 signals name Dexmate.
12 facts on file.
Genesis AI markets Eno, a general-purpose robot, to enterprise customers for prospective deployments across operational settings.
Darker bar: ahead of the other company on that measure.
Genesis AI is a private Paris–San Carlos full-stack robotics company developing the GENE robot foundation model, dexterous manipulation hardware and the Eno general-purpose robot. It raised a company-announced $105M seed in Jul-25, demonstrated GENE-26.5 manipulation tasks in May-26, unveiled Eno and announced a strategic deployment partnership with LG CNS on Jun-16-26, but no customer deployment or earned robotics revenue has been publicly verified as of Sep-15-26. Its distinguishing position is the combination of simulation, human-skill data capture, proprietary hands and a non-humanoid mobile robot; the open question is whether the announced end-2026 production and customer-deployment target will convert demonstrations into repeatable field operations.
64 signals name Genesis AI.
61 facts on file.
Genesis AI ranks 72 on the Humanoids 100 with a score of 58; Dexmate ranks 73 with 57. Dexmate is ahead on production and leverage. Genesis AI is ahead on commercials, progress and firepower. Level on deployment, technology and positioning. Dexmate is based in United States, Genesis AI in Palo Alto, United States. Genesis AI: Private, founded 2024. Dexmate is named in 12 signals and Genesis AI in 64.
Genesis AI ranks 72 on the Humanoids 100 with a score of 58; Dexmate ranks 73 with 57. Dexmate is ahead on production and leverage. Genesis AI is ahead on commercials, progress and firepower. Level on deployment, technology and positioning. Dexmate is based in United States, Genesis AI in Palo Alto, United States. Genesis AI: Private, founded 2024. Dexmate is named in 12 signals and Genesis AI in 64. Both company files carry the scores on eight measures, the facts with sources and the latest signals.
Members see every signal and fact behind both companies, the live ranking, the questions the signals answer and the week explained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →